blood cancer

Yellow arrow going opposite direction as white arrows

Biotech

BioNTech passes on Autolus' CAR-T amid pipeline prioritization

One year after securing a chance to co-develop the Autolus prospect, BioNTech let the option expire as part of its portfolio prioritization.

Nick Paul Taylor Mar 20, 2025 9:11am

whale jumping out of water

Orca prepares to make market plunge after phase 3 win

Mar 17, 2025 7:00am

An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

Ono pays $280M upfront for Ionis' phase 2 blood cancer med

Mar 12, 2025 6:30am

A series of dice with a bag on them illustrating cost cuts

Ryvu loses 30% of staff in focus on ph. 3 blood cancer trials

Feb 25, 2025 10:00am

Three blocks displaying from left to right a person a handshake and another person

Exicure buys GPCR's US unit and clinical-stage blood cancer drug

Jan 23, 2025 5:01am

Golfer devastated after just barely missing a putt

Incyte scraps cancer-related anemia program after ph. 1/2 fail

Dec 13, 2024 2:30pm